Zhejiang Wolwo Bio-Pharmaceutical Hits Day High with 6.38% Surge

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 6.38% on March 27, 2026. The stock reached an intraday high of CNY 25.65, reflecting a strong day of trading activity. This performance stands in contrast to the China Shanghai Composite, which only rose by 0.63% on the same day. Over the past week, Zhejiang Wolwo has shown a 1.96% increase, while the broader market has faced a decline of 1.09%. Year-to-date, however, the stock has seen a decrease of 10.05%, compared to a smaller decline of 1.39% in the China Shanghai Composite. Notably, the company has demonstrated resilience over the past year, achieving a return of 20.34%, outpacing the index's 16.01% gain. The company has reported impressive financial metrics, including a net profit growth of 36.44% and a robust operating cash flow of CNY 392.77 million. With a market capitalization of CNY 12,510 million, Zhejiang Wolwo continues to solidify its position within the pharmaceuticals and biotechnology sector.